Electronic supplementary material
What is Known:
• TDF is suspected to affect the growth of HIV-exposed uninfected infants.
• Non-TDF-based cART regimes for prevention of mother-to-child transmission of HIV often result in transient anemia in the infant.
What is New:
• TDF appears to have no major side effects regarding the growth of HIV-exposed uninfected infants.
• Our research suggests a potential delayed effect of TDF on neutrophils at 3 months of age in these infants.